Sunday, 02 October 2022



LATEST NEWS Women's Asia Cup : Preparing by playing on slower pitches in Bangalore helped here : Jemimah Rodrigues Women's Asia Cup : Jemimah Rodrigues played really well, we expect things like this from her : Harmanpreet Kaur National Games : I desperately wanted to take part in Gujarat 2022 : injured Bajrang Punia Blood donation our responsibility to help each other : Mansukh Mandaviya Women's Asia Cup : Jemimah Rodrigues makes career-best 76 in India's convincing 41-run win over Sri Lanka Had some reflections about Thiruvananthapuram loss, now it's about putting those right in Guwahati : Wayne Parnell Home Minister Anil Vij's Janata Darbar, Rohtak's Havildar suspended, directions for transfer of two SHOs Google receives 37,282 complaints from Indian users in Aug Shweta Tiwari, Manav Gohil visit Siddhivinayak temple for blessings Feels great to reach the National Games final just before Pro Kabaddi League : Nitin Tomar Hindi trailer of Chiranjeevi's 'GodFather' promises action feast for fans National Games : Badminton star H.S Prannoy returns to court with a facile victory Prime Minister Narendra Modi interacts with Delhi Metro tunnel workers via live Vi 5G network Chobbar Trailer: Jayy Randhawa Shines Bright In New Project & It Is All The Viewers Wanted Rahul Bhandari Emphasises On Optimum Utilization Of Resources To Inform About Pro-People Schemes MLA Tarunpreet Singh Sondh Kickstarts paddy procurement in Khanna grain market, interacts with farmers Jugni: Diljit Dosanjh Finally Unveils The Poster & Title Of His Upcoming Collaboration With Diamond Platnumz Chief Minister Jai Ram Thakur announces new Sub Tehsil office to Yol and to upgrade PHC Badoi to CHC WhatsApp bans 23 lakh bad accounts in India as new PDP bill takes shape Shraddha Arya recalls on-screen chemistry with Dheeraj Dhoopar in 'Kundali Bhagya' Brandon King, Fabian Allen take Jamaica Tallawahs to a third CPL title


Pfizer to explore pneumococcal jab with 3rd booster of Covid vax

Coronavirus, COVID 19, Novel Coronavirus, Fight Against Corona,  Covid-19 Vaccine, Oxygen, #OxygenCylinders, #oxygen, Oxygen Cylinders, SARS-CoV-2, Oxygen Plants, Pfizer, Oxygen Concentrator, Oxygen supply, Liquid Medical Oxygen, Pfizer-BioNTech Covid-19 vaccine

Web Admin

Web Admin

5 Dariya News

New York , 24 May 2021

Pfizer on Monday announced a study to explore coadministration of its pneumococcal vaccine along with a third dose of the Pfizer-BioNTech Covid-19 vaccine in older adults.Pfizer, in a statement, announced that "the first enrolled subjects have received their immunisations as part of a new study in adults ages 65 or older exploring the coadministration of the company's 20-valent pneumococcal conjugate vaccine (20vPnC) candidate following a booster dose of the Pfizer-BioNTech Covid-19 vaccine, currently authorised by the Food and Drug Administration (FDA) under an emergency use authorisation (EUA)".The trial aims to describe safety when both vaccines are co-administered, with follow-up six months after vaccination and to describe immune responses produced by each of the vaccines.The trial will include 600 adults who will be recruited from the pivotal Phase 3 Pfizer-BioNTech Covid-19 vaccine trial and will have received their second dose of the vaccine at least six months prior to entering the coadministration study.The participants will be randomised to one of three groups: 20vPnC plus Pfizer-BioNTech Covid-19 vaccine booster; 20vPnC plus placebo; and Pfizer-BioNTech Covid-19 vaccine booster plus placebo.Boosters and new versions of vaccines that target the Covid variants are already being explored by both Pfizer and Moderna.Pfizer CEO Albert Bourla had announced that Covid vaccine recipients will "likely" need a third dose between six to 12 months after they're fully vaccinated. The company is now testing a third booster shot of its vaccine on fully vaccinated people.US pharmaceutical Moderna in its Phase 2 study found that a third booster shot of its Covid vaccine can rapidly increase the level of antibodies in previously inoculated people.The 20vPnC candidate vaccine is in development for the prevention of invasive disease and pneumonia caused by 20 serotypes of Streptococcus pneumoniae in the vaccine in adults ages 18 years and older.


Tags: Coronavirus , COVID 19 , Novel Coronavirus , Fight Against Corona , Covid-19 Vaccine , Oxygen , #OxygenCylinders , #oxygen , Oxygen Cylinders , SARS-CoV-2 , Oxygen Plants , Pfizer , Oxygen Concentrator , Oxygen supply , Liquid Medical Oxygen , Pfizer-BioNTech Covid-19 vaccine



related news




Photo Gallery



Video Gallery



5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD